IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- PMID: 19487306
- DOI: 10.1189/JLB.0109046
IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
Abstract
IL-17-producing CD4+ T lymphocytes (Th17) are currently considered relevant participants in the pathogenesis of psoriasis skin lesions. However, little is known about the potential role of IL-17-producing CD8+ T cells, which are also present at the psoriatic plaque. We have addressed the functional characterization of this CD8+ subtype of T lymphocytes from psoriasis patients. Our results show that CD8+IL-17+ cells from psoriasis-inflamed skin tissue produce TNF-alpha and IFN-gamma (Th1-related cytokines) as well as IL-17, IL-21, and IL-22 (Th17-related cytokines) efficiently. A significant up-regulation of the RORC transcription factor is also observed. These cells are refractory to Tregs but show a proliferative response to anti-CD3/CD28 stimulation that is enhanced by IL-12 and IL-15. Blocking of TNF-alpha activity inhibits TCR-mediated activation and IL-17 production. CD8+IL-17+ T cells are cytotoxic cells that display TCR/CD3-mediated cytotoxic abilities to kill target cells. Thus, CD8+IL-17+ T cells share some key features with Th17 cells and exhibit remarkable differential abilities attributable to the CD8+ lineage of T lymphocytes, adding new insights into the functional resources of IL-17-producing cells from human epidermis that could be of potential interest to our understanding of the pathogenesis of psoriasis.
Similar articles
-
A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.Eur J Immunol. 2009 Jul;39(7):1716-25. doi: 10.1002/eji.200939412. Eur J Immunol. 2009. PMID: 19544308
-
The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.Eur J Immunol. 2009 Jun;39(6):1480-93. doi: 10.1002/eji.200838908. Eur J Immunol. 2009. PMID: 19449310
-
Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.Arthritis Rheum. 2010 Feb;62(2):430-40. doi: 10.1002/art.27203. Arthritis Rheum. 2010. PMID: 20112373
-
Immunopathogenesis and role of T cells in psoriasis.Clin Dermatol. 2007 Nov-Dec;25(6):574-80. doi: 10.1016/j.clindermatol.2007.08.012. Clin Dermatol. 2007. PMID: 18021895 Review.
-
Targeting the development and effector functions of TH17 cells.Semin Immunol. 2007 Dec;19(6):383-93. doi: 10.1016/j.smim.2007.10.016. Epub 2008 Jan 14. Semin Immunol. 2007. PMID: 18083530 Review.
Cited by
-
Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis.Curr Rheumatol Rep. 2015 Aug;17(8):55. doi: 10.1007/s11926-015-0529-9. Curr Rheumatol Rep. 2015. PMID: 26209291 Review.
-
Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis.Exp Dermatol. 2022 Nov;31(11):1764-1778. doi: 10.1111/exd.14657. Epub 2022 Aug 19. Exp Dermatol. 2022. PMID: 36054319 Free PMC article. Clinical Trial.
-
Regulation of Dendritic Cell Function in Inflammation.J Immunol Res. 2015;2015:743169. doi: 10.1155/2015/743169. Epub 2015 Jul 2. J Immunol Res. 2015. PMID: 26229971 Free PMC article. Review.
-
Altered expression of regulatory molecules in the skin of psoriasis.Immunol Res. 2018 Dec;66(6):649-654. doi: 10.1007/s12026-018-9057-9. Immunol Res. 2018. PMID: 30613859
-
Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective.J Exp Med. 2020 Jan 6;217(1):e20191123. doi: 10.1084/jem.20191123. J Exp Med. 2020. PMID: 31727781 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials